A Game-Changer for Autoimmune Diseases
Researchers at the University of Chicago’s Pritzker School of Molecular Engineering have developed a groundbreaking “inverse vaccine” that could potentially reverse the course of autoimmune diseases like multiple sclerosis, type 1 diabetes, and Crohn’s disease.
Unlike typical vaccines that train the immune system to fight off invaders, this inverse vaccine aims to delete the immune system’s memory of a particular molecule, preventing it from attacking the body’s own cells.
How Does It Work?
Traditional vaccines educate the immune system to recognize harmful agents like viruses or bacteria.
In contrast, the inverse vaccine erases a specific immune memory, a function that could be highly beneficial for treating autoimmune diseases, where the immune system mistakenly attacks the body’s healthy cells.
The innovation relies on how the liver naturally marks certain molecules as “do not attack,” preventing autoimmune reactions.
By coupling an antigen (the target of the immune system) with a molecule that the liver recognizes as friendly, the researchers were able to halt the autoimmune reactions associated with diseases like multiple sclerosis.
Beyond Prevention to Cure
“In the past, we showed that we could use this approach to prevent autoimmunity,” said Jeffrey Hubbell, the lead author of the new paper.
“But what is so exciting about this work is that we have shown that we can treat diseases like multiple sclerosis after there is already ongoing inflammation.”
The Science Behind It
The immune system’s T cells are designed to recognize and eliminate unwanted cells and molecules. However, these T cells can sometimes misidentify healthy cells as invaders.
In multiple sclerosis, for example, T cells attack the protective coating around nerves known as myelin.
Hubbell and his team discovered that tagging molecules with a specific sugar could “teach” the immune system to tolerate them, effectively reversing the autoimmune response.
Next Steps: Human Trials and Commercialization
While treatments for autoimmune diseases currently rely on drugs that broadly suppress the immune system, they can also leave patients vulnerable to infections.
The inverse vaccine, on the other hand, could offer a more targeted and safer approach.
The next step involves testing the inverse vaccine in humans. Initial Phase I safety trials are already underway for people with celiac disease and multiple sclerosis.
The research is funded by pharmaceutical company Anokion SA, which Hubbell co-founded, and the Alper Family Foundation.
“There are no clinically approved inverse vaccines yet, but we’re incredibly excited about moving this technology forward,” says Hubbell.
In summary, this revolutionary vaccine could dramatically change how we approach the treatment of autoimmune diseases, offering a targeted and potentially curative strategy.
If successful in clinical trials, it could usher in a new era of autoimmune disease treatment, offering hope to millions suffering from these conditions.
If you care about nutrition, please read studies about how the Mediterranean diet could protect your brain health, and this plant nutrient could help reduce high blood pressure.
For more information about nutrition, please see recent studies that olive oil may help you live longer, and vitamin D could help lower the risk of autoimmune diseases.
The research findings can be found in Nature Biomedical Engineering.
Follow us on Twitter for more articles about this topic.
Copyright © 2023 Knowridge Science Report. All rights reserved.
